Product
Sm-TSP-2/Alhydrogel vaccine plus AP 10-701
1 clinical trial
2 indications
Indication
SchistosomiasisIndication
Schistosoma mansoniClinical trial
A Phase I/II Study of the Safety, Immunogenicity, and Efficacy of Sm-TSP-2/Alhydrogel® With or Without AP 10-701 for Intestinal Schistosomiasis in Healthy Ugandan AdultsStatus: Active (not recruiting), Estimated PCD: 2024-09-01